Get the Stockscreener App
34.76
2.12%
0.72
Guardian Pharmacy Services Inc stock is traded at $34.76, with a volume of 206.14K.
It is up +2.12% in the last 24 hours and up +10.56% over the past month.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
See More
Previous Close:
$34.04
Open:
$34.1
24h Volume:
206.14K
Relative Volume:
0.86
Market Cap:
$2.20B
Revenue:
$1.33B
Net Income/Loss:
$-75.88M
P/E Ratio:
-23.49
EPS:
-1.48
Net Cash Flow:
$37.92M
1W Performance:
+4.32%
1M Performance:
+10.56%
6M Performance:
+22.09%
1Y Performance:
+77.44%
1-Day Range:
$33.43
$35.15
1-Week Range:
$32.65
$35.15
52-Week Range:
$17.78
$37.43
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Name
Guardian Pharmacy Services Inc
Sector
Industry
Phone
(404) 810-0089
Address
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRDN
Guardian Pharmacy Services Inc
|
34.76 | 2.16B | 1.33B | -75.88M | 37.92M | -1.48 |
|
HCA
Hca Healthcare Inc
|
544.41 | 121.16B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
244.80 | 21.12B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.03 | 13.05B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
202.31 | 12.51B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
212.05 | 12.39B | 4.11B | 239.98M | 193.10M | 4.12 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Outperform |
| Oct-21-24 | Initiated | Truist | Buy |
Guardian Pharmacy Services Inc Stock (GRDN) Latest News
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Guardian Pharmacy Services (GRDN) to Release Quarterly Earnings on Wednesday - MarketBeat
GRDN: Expanding market share in assisted living pharmacy through organic growth and disciplined M&A - TradingView
Aug Setups: Is Guardian Pharmacy Services Inc stock showing strong momentumJuly 2025 Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Guardian Pharmacy Services, Inc. (GRDN): Analyst Ratings Suggest a Promising 6% Upside for Healthcare Investors - DirectorsTalk Interviews
Weekly Trades: Can Guardian Pharmacy Services Inc grow without external funding2025 Performance Recap & Breakout Confirmation Trade Signals - baoquankhu1.vn
Can Guardian Pharmacy Services Inc. sustain its profitabilityJuly 2025 Reactions & Precise Buy Zone Tips - mfd.ru
Guardian Pharmacy Services : Hosts Annual Sales & Account Management Meeting in Atlanta - marketscreener.com
TimesSquare Capital Management LLC Acquires 45,950 Shares of Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
Revenue Check: What technical charts say about Guardian Pharmacy Services Inc. stock2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
New York State Common Retirement Fund Sells 347,524 Shares of Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
Wall Street Recap: Is Guardian Pharmacy Services Inc stock undervalued right nowQuarterly Market Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference - The Joplin Globe
Guardian Pharmacy to present at Raymond James investor conference Mar. 2 - Stock Titan
Will Guardian Pharmacy Services Inc. outperform its industry peersJuly 2025 Short Interest & Growth Oriented Trading Recommendations - mfd.ru
Guardian Pharmacy Services, Inc (GRDN): Stock Analysis Reveals 2.67% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call - marketscreener.com
Guardian Pharmacy sets March 11 call on 2025 results - Stock Titan
Guardian Pharmacy Services : of Orlando Opens Larger Facility to Support Business Growth - marketscreener.com
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Potential 8.12% Upside Beckons Investors - DirectorsTalk Interviews
A Look At The Fair Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN) - Yahoo Finance
Short Interest in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Rises By 33.3% - MarketBeat
Bond Watch: Is Guardian Pharmacy Services Inc stock showing strong momentumJuly 2025 Volume & Consistent Profit Alerts - baoquankhu1.vn
Setup Watch: How does Guardian Pharmacy Services Inc correlate with NasdaqJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enovis (ENOV), Guardian Pharmacy Services, Inc. Class A (GRDN) and Biogen (BIIB) - The Globe and Mail
Rakuten Investment Management Inc. Takes Position in Guardian Pharmacy Services, Inc. $GRDN - Defense World
Guardian Pharmacy Services’ (GRDN) Flat 2026 Revenue Guide: Pragmatic Planning or Fading Growth Ambition? - simplywall.st
Stephens Is Bullish on Guardian Pharmacy Services, Inc. (GRDN) After 2026 Forecast Update - Finviz
Stephens is bullish on Guardian Pharmacy Services, Inc. (GRDN) after 2026 forecast update - MSN
12 Cheap Small-Cap Stocks to Invest In Before the Next Breakout - Insider Monkey
Bear Alert: Whats the profit margin of Guardian Pharmacy Services IncJuly 2025 Reactions & Verified Entry Point Detection - baoquankhu1.vn
Guardian Pharmacy Services, Inc (GRDN): Investor Outlook With 29% Upside Potential - DirectorsTalk Interviews
Guardian Pharmacy Services : Right Dose Pharmacy Opens New Ankeny, Iowa Headquarters to Meet Growing Demand for Long-Term Care Pharmacy Services - marketscreener.com
Guardian Pharmacy Services (NYSE:GRDN) Shares Down 6.9%Time to Sell? - MarketBeat
Guardian Pharmacy Services : Participates in J.P. Morgan Healthcare Conference - marketscreener.com
Growth Report: Is Guardian Pharmacy Services Inc stock undervalued right nowDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn
Is Dolby Laboratories Inc forming a breakout patternQuarterly Growth Report & Safe Entry Momentum Tips - baoquankhu1.vn
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Guardian Pharmacy Services stock price target raised to $36 at Stephens - Investing.com Nigeria
Guardian pharmacy services forecasts continued double-digit EBITDA growth By Investing.com - Investing.com Nigeria
Guardian Pharmacy Reaffirms 2025 Outlook, Issues 2026 Guidance - TipRanks
Guardian pharmacy services forecasts continued double-digit EBITDA growth - Investing.com
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook - marketscreener.com
Despite drug price cuts, Guardian Pharmacy sees 2026 EBITDA growth - Stock Titan
With 35% ownership, Guardian Pharmacy Services, Inc. (NYSE:GRDN) has piqued the interest of institutional investors - Yahoo Finance
Winners Losers: How sustainable is Guardian Pharmacy Services Inc. stock dividend payoutMarket Movement Recap & Capital Efficiency Focused Ideas - Улправда
Guardian Pharmacy Services Inc Stock (GRDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):